President Biden Withdraws from 2024 Race, Highlights Healthcare Achievements

In a surprising turn of events, President Joe Biden announced at his Delaware vacation home that he will not run in the 2024 presidential race, following weeks of mounting pressure. This decision marks the end of Biden’s over 50-year political career, during which he achieved significant milestones, particularly in healthcare reform.

Biden's tenure includes the landmark 2022 Inflation Reduction Act (IRA), which allows Medicare to negotiate prices for its ten costliest prescription drugs starting in 2026. This legislation, touted as the most significant drug pricing reform to date, is projected to save the U.S. government $164 billion over ten years. In his announcement, Biden highlighted "lowering prescription drug costs for seniors" as a key victory, underscoring his commitment to reducing high drug prices—a longstanding priority for Democrats.

Additionally, the IRA imposes penalties for drug price increases exceeding the rate of inflation and caps out-of-pocket costs for Medicare beneficiaries. Efforts by drugmakers to challenge the law have largely been unsuccessful in court, although some companies continue to appeal. Biden also praised the $35 monthly cap on insulin, attributing price cuts by Eli Lilly, Sanofi, and Novo Nordisk to the influence of the IRA. His achievements in healthcare reform stand as a notable part of his legacy as he steps back from the political arena.

Click here to read the original news story.